Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Martin Edwards Insider Profile
4 Followers
Martin Edwards, Director at CoLucid Pharmaceuticals, holds 0.00 shares in CoLucid Pharmaceuticals (Ticker: CLCD), holds ― shares in KalVista Pharmaceuticals (Ticker: KALV), holds ― shares in Inozyme Pharma (Ticker: INZY). Most recently, Martin Edwards ― shares of CoLucid Pharmaceuticals on ― for an estimated value of ―.
Martin Edwards CoLucid Pharmaceuticals (CLCD)Director
CoLucid Pharmaceuticals (CLCD)
Director
Not Ranked
Ranked #23,162 out of 100,202 Corporate Insiders
Martin Edwards has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Martin Edwards holds in companies
Most Profitable Insider Trade
The most profitable trade made by Martin Edwards
Martin Edwards's Trading History
CoLucid Pharmaceuticals
―
―
―
$0.00
KalVista Pharmaceuticals
―
Director
―
―
Inozyme Pharma
―
Director
―
―
Reata Pharmaceuticals
Sep 26, 2023
―
Uninformative Sell
―
$0.00
Verona Pharma
Nov 22, 2023
Director
Informative Buy
61.74K
$6.08M
Morphic Holding
Aug 21, 2024
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Martin Edwards's performance on stock
You May Also Like
Martin Edwards insider profile FAQ
What is the percentage of profitable transactions made by Martin Edwards?
The percentage of profitable transactions made by Martin Edwards is ―.
What is the average return per transaction made by Martin Edwards?
The average return per transaction made by Martin Edwards is ―.
What stocks does Martin Edwards hold?
Martin Edwards holds: CLCD, KALV, INZY, RETA, VRNA, MORF stocks.
What was Martin Edwards’s latest transaction?
Martin Edwards latest transaction was an Uninformative Buy of ―.
What was Martin Edwards's most profitable transaction?
Martin Edwards’s most profitable transaction was an Informative Buy of VRNA stock on November 22, 2023. The return on the trade was 176.20%.
What is Martin Edwards's role in CoLucid Pharmaceuticals?
Martin Edwards's role in CoLucid Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.